NMRA vs TYL · $283.5M cap vs P/E 89, rev $2.14B
Neumora Therapeutics, Inc. (NMRA) versus Tyler Technologies Inc (TYL) — a side-by-side from cached financials, not a winner call.
Neumora Therapeutics, Inc. (NMRA) is a biotechnology company listed on NASDAQ.
Tyler Technologies Inc (TYL) is a software - application company listed on US.
NMRA does not have a complete income-statement cache yet.
Latest reported TYL revenue for 2024-12-31 was $2.14B. Net income was $263.0M. Revenue was up 9.5% from 2023-12-31 to 2024-12-31. TYL currently screens at market cap $25.57B and trailing P/E 89.3.
NMRA currently screens at market cap $283.5M. TYL currently screens at market cap $25.57B and trailing P/E 89.3.
Not investment advice. Open the NMRA and TYL stock pages for the full models.
Not investment advice.